Korean J Hematol 2008; 43(4):
Published online December 31, 2008
https://doi.org/10.5045/kjh.2008.43.4.219
© The Korean Society of Hematology
임지영 김보경 문설경 민창기
가톨릭대학 의과대학 성모병원 내과
Background: Mesenchymal stem cells (MSCs) may be useful for reducing graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The GVHD and a graft-versus-leukemia (GVL) effect are inversely related. We therefore wanted to determine whether MSCs can preserve the GVL effect following experimental allo-HSCT. Methods: After non-myeloablative allogeneic hematopoietic stem cell transplantation (NM-HSCT) using C57BL/6 (H-2b)→B6D2F1 (H-2b/d), some mice received donor lymphocyte infusion (DLI) for induction of GVL effects by virtue of complete chimerism (CC), while the other groups did not receive DLI with persistence of mixed chimerism (MC). All mice were inoculated subcutaneously with P815 tumor cells and were intravenously treated with either donor MSCs or diluents. Results: Between the DLI-treated groups with CC, tumor-related deaths and tumor growths were comparable irrespective to the infusion of MSCs. On the contrary, among mice without DLI which showed MC, the administration of MSCs significantly delayed tumor-related deaths compared to those without the administration of MSCs (50-day percent survival, 54.5% vs. 18.1%, P=0.0225). In the MC animals, tumor growth seemed to be more delayed in the mice injected with MSCs than in the controls (P=0.09). Donor MSCs injection was associated with increased donor effector/memory CD62L- T cells in MC but not in CC. Conclusion: In spite of the observed immunosuppressive effects of donor MSCs, our results indicate that the GVL effects were not influenced by the injection of MSCs but that under a given condition such as MC, the injection of donor MSCs could result in enhanced GVL effects.
Keywords Mesenchymal stem cell, Graft-versus-host disease, Graft-versus-leukemia effect, Allogeneic hematopoietic stem cell transplantation
Korean J Hematol 2008; 43(4): 219-231
Published online December 31, 2008 https://doi.org/10.5045/kjh.2008.43.4.219
Copyright © The Korean Society of Hematology.
임지영 김보경 문설경 민창기
가톨릭대학 의과대학 성모병원 내과
Ji Young Lim, Bo Gyeong Kim, Seol Kyung Moon, Chang Ki Min
Department of Internal Medicine, Collage of Medicine, St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
Background: Mesenchymal stem cells (MSCs) may be useful for reducing graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The GVHD and a graft-versus-leukemia (GVL) effect are inversely related. We therefore wanted to determine whether MSCs can preserve the GVL effect following experimental allo-HSCT. Methods: After non-myeloablative allogeneic hematopoietic stem cell transplantation (NM-HSCT) using C57BL/6 (H-2b)→B6D2F1 (H-2b/d), some mice received donor lymphocyte infusion (DLI) for induction of GVL effects by virtue of complete chimerism (CC), while the other groups did not receive DLI with persistence of mixed chimerism (MC). All mice were inoculated subcutaneously with P815 tumor cells and were intravenously treated with either donor MSCs or diluents. Results: Between the DLI-treated groups with CC, tumor-related deaths and tumor growths were comparable irrespective to the infusion of MSCs. On the contrary, among mice without DLI which showed MC, the administration of MSCs significantly delayed tumor-related deaths compared to those without the administration of MSCs (50-day percent survival, 54.5% vs. 18.1%, P=0.0225). In the MC animals, tumor growth seemed to be more delayed in the mice injected with MSCs than in the controls (P=0.09). Donor MSCs injection was associated with increased donor effector/memory CD62L- T cells in MC but not in CC. Conclusion: In spite of the observed immunosuppressive effects of donor MSCs, our results indicate that the GVL effects were not influenced by the injection of MSCs but that under a given condition such as MC, the injection of donor MSCs could result in enhanced GVL effects.
Keywords: Mesenchymal stem cell, Graft-versus-host disease, Graft-versus-leukemia effect, Allogeneic hematopoietic stem cell transplantation
Seok Lee, Seon Yang Park, Byoung Kook Kim, Hong Ghi Lee, Chan Hyung Park, Dong Ki Nam, Hugh Chul Kim, Kyung Hee Lee, Myung Soo Hyun, Do Yeun Oh, Young Cheol Kim, Soon Nam Lee, Chu Myong Seong
Korean J Hematol 1999; 34(2): 252-262Jieun Uhm
Blood Res 2023; 58(S1): S109-S113Hee Won Cho, Young Bae Choi, Eun Sang Yi, Ji Won Lee, Ki Woong Sung, Hong Hoe Koo, and Keon Hee Yoo
Blood Res 2016; 51(4): 242-248